SFM
VRTX icon

Soros Fund Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Soros Fund Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,600
Closed -$394K – 316
2017
Q1 		$394K Buy
+3,600
New +$317K 0.01% 181
2016
Q3 		– Sell
-6,300
Closed -$542K – 274
2016
Q2 		$542K Buy
+6,300
New +$544K 0.02% 145
2015
Q2 		– Sell
-56,912
Closed -$6.71M – 299
2015
Q1 		$6.71M Buy
+56,912
New +$6.82M 0.08% 151
2014
Q2 		– Sell
-10,000
Closed -$707K – 443
2014
Q1 		$707K Buy
+10,000
New +$792K 0.01% 254

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return